|
|
|
|
|
|
|
HUM-MOLGEN
-> Events
-> Meetings and Conferences |
|
|
|
| |
|
June 30, 2018 |
|
|
|
|
|
|
|
|
Compliance Training Panel, Online
2018-07-12
This Webinar will explain what 21 CFR Part 11 is, why it is important to FDA regulated companies and how conformance to Part 11 differs from just having good IT security. Procedures for controlling electronic signatures and electronic records as described in the FDA Guidance will be explained.
FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient.
FDA has set up regulations that address both data security and patient safety. We will show how 21 CFR part 11 considers both.
The confusion over the original FDA regulation and its subsequent “selective enforcement” will be explained. FDA requirements for 21CFR Part 11 validation will be explained. the requirements are composed of technical and procedural aspects. open, closed and hybrid (paper and electronic) systems will be explained.
|
|
|
|
|
|
Organized by:
|
|
Compliance Training Panel |
|
Invited Speakers:
|
|
Edwin Waldbusser
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2018-07-12
|
|
|
|
|
|
Registration:
|
|
https://www.compliancetrainingpanel.com/Webinar/Topic?WB=MD00103
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|